FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approved a supplemental application for UROXATRAL (alfuzosin HCl) from Advanz Pharma US Corp. The action confirms regulatory clearance related to the supple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Uroxatral (Alfuzosin)

Snippet

SUPPL AP for UROXATRAL (ALFUZOSIN HCL)